Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Presentation and Outcomes
Publication
, Conference
Sutton, PE; Shah, S
Published in: MULTIPLE SCLEROSIS JOURNAL
2022
Duke Scholars
Published In
MULTIPLE SCLEROSIS JOURNAL
EISSN
1477-0970
ISSN
1352-4585
Publication Date
2022
Volume
28
Issue
1_SUPPL
Start / End Page
146 / 147
Related Subject Headings
- Neurology & Neurosurgery
- 5202 Biological psychology
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sutton, P. E., & Shah, S. (2022). Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Presentation and Outcomes. In MULTIPLE SCLEROSIS JOURNAL (Vol. 28, pp. 146–147).
Sutton, P. E., and S. Shah. “Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Presentation and Outcomes.” In MULTIPLE SCLEROSIS JOURNAL, 28:146–47, 2022.
Sutton PE, Shah S. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Presentation and Outcomes. In: MULTIPLE SCLEROSIS JOURNAL. 2022. p. 146–7.
Sutton, P. E., and S. Shah. “Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Presentation and Outcomes.” MULTIPLE SCLEROSIS JOURNAL, vol. 28, no. 1_SUPPL, 2022, pp. 146–47.
Sutton PE, Shah S. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Presentation and Outcomes. MULTIPLE SCLEROSIS JOURNAL. 2022. p. 146–147.
Published In
MULTIPLE SCLEROSIS JOURNAL
EISSN
1477-0970
ISSN
1352-4585
Publication Date
2022
Volume
28
Issue
1_SUPPL
Start / End Page
146 / 147
Related Subject Headings
- Neurology & Neurosurgery
- 5202 Biological psychology
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences